Ashley Katherine Clark, MD
Dermatology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 22
- 6 carriers
- Offices
- 4
Offices
4 locations · Golden State Dermatology Associates, Inc. · Springhouse Dermatology Inc
Looking this up.
Plans that list them
22 plans · 6 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Clark’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
22 of 22 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A176366 · Current
Licensed to practise in California · since 2022 · expires 2028-04-30 · University of California, Davis School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$170,866
Medicare paid this office $170,866 for 363 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 123 | $29,347 | $108 |
| Short return visit (20+ min) | 139 | $16,715 | $78 |
| Destruction of precancer skin growth, 1 growth | 158 | $12,947 | $53 |
| Biopsy of related skin growth, first growth | 96 | $10,977 | $95 |
| New patient visit (30+ min) | 112 | $9,987 | $89 |
See all 13 services
| Return visit (30+ min) | 123 | $29,347 | $108 |
| Short return visit (20+ min) | 139 | $16,715 | $78 |
| Destruction of precancer skin growth, 1 growth | 158 | $12,947 | $53 |
| Biopsy of related skin growth, first growth | 96 | $10,977 | $95 |
| New patient visit (30+ min) | 112 | $9,987 | $89 |
| New patient visit (45+ min) | 72 | $9,043 | $126 |
| Destruction of skin growth, 1-14 growths | 51 | $7,337 | $113 |
| Destruction of precancer skin growth, 2-14 growths | 119 | $5,607 | $7 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 14 | $4,689 | $313 |
| Destruction of precancer skin growth, 15 or more growths | 11 | $2,765 | $173 |
| Punch biopsy, first skin growth | 16 | $2,185 | $129 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 12 | $1,622 | $125 |
| Biopsy of related skin growth, each additional growth | 18 | $1,251 | $52 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 29 | More than 80% of doctors who do this |
| Removal of skin lesions | 537 | More than 87% of doctors who do this |
| Removal or shaving of skin growth | 39 | More than 77% of doctors who do this |
| Skin biopsy | 173 | More than 83% of doctors who do this |
Who their Medicare patients are
363 Original Medicare patients in 2024. Average age 76 · Women 64% · Also on Medicaid 6% · Health risk score 0.93. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 65% · Diabetes 29% · Coronary heart disease 22% · Cancer 19% · Atrial fibrillation 17% · Chronic kidney disease 12% · Depression 11% · Heart failure 9% · COPD 7% · Stroke 7% · Dementia 6%.
The office billed $432,239, Medicare allowed $229,449 and paid $170,866; for 2,767 services of 49 kinds; $43,462 of it was for drugs given in the office and $127,404 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 363 | 2,767 | 76 | 0.93 | $432,239 | $170,866 |
| 2023 | 291 | 2,753 | 77 | 0.93 | $382,241 | $155,555 |
| 2022 | 219 | 1,147 | 77 | 0.91 | $173,735 | $63,751 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 127 | $28,183 | $113 |
| Short return visit (20+ min) | 127 | $15,557 | $77 |
| Destruction of precancer skin growth, 1 growth | 113 | $9,740 | $56 |
| New patient visit (45+ min) | 56 | $7,975 | $142 |
| Destruction of skin growth, 1-14 growths | 47 | $6,637 | $111 |
| New patient visit (30+ min) | 69 | $6,043 | $88 |
| Biopsy of related skin growth, first growth | 44 | $5,411 | $98 |
| Destruction of precancer skin growth, 2-14 growths | 83 | $4,413 | $7 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 13 | $4,345 | $290 |
| Destruction of precancer skin growth, 15 or more growths | 14 | $4,169 | $167 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $1,871 | $125 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 13 | $1,528 | $109 |
| Biopsy of related skin growth, each additional growth | 11 | $628 | $52 |
2022: 9 services
| Return visit (30+ min) | 99 | $15,552 | $122 |
| Short return visit (20+ min) | 75 | $7,553 | $84 |
| Destruction of skin growth, 1-14 growths | 53 | $6,647 | $111 |
| New patient visit (45+ min) | 34 | $5,253 | $154 |
| Destruction of precancer skin growth, 1 growth | 73 | $4,017 | $48 |
| New patient visit (30+ min) | 33 | $2,949 | $89 |
| Biopsy of related skin growth, first growth | 30 | $2,860 | $92 |
| Destruction of precancer skin growth, 2-14 growths | 54 | $2,300 | $7 |
| Punch biopsy, first skin growth | 11 | $1,401 | $127 |
Drugs they prescribed that Part D paid
$40,896
Pharmacies billed $40,896 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 415) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
390 generic and 25 brand-name prescriptions · $40,896 in drug cost · 15 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tacrolimus | 25 | $2,567 | $103 |
| Fluorouracil | 24 | $1,456 | $61 |
| Halobetasol Propionate | 17 | $1,240 | $73 |
| Clobetasol Propionate | 33 | $1,168 | $35 |
| Triamcinolone Acetonide | 80 | $912 | $11 |
See all 8 drugs
| Tacrolimus | 25 | $2,567 | $103 |
| Fluorouracil | 24 | $1,456 | $61 |
| Halobetasol Propionate | 17 | $1,240 | $73 |
| Clobetasol Propionate | 33 | $1,168 | $35 |
| Triamcinolone Acetonide | 80 | $912 | $11 |
| Desonide | 13 | $682 | $52 |
| Ketoconazole | 37 | $488 | $13 |
| Mupirocin | 38 | $301 | $8 |
Year by year
| 2024 | 415 | 174 | 0% (0) | 6% | $40,896 |
| 2023 | 372 | 169 | 0% (0) | 5% | $53,403 |
| 2022 | 201 | 96 | 0% (0) | None | $9,250 |
| 2021 | 37 | 14 | 0% (0) | None | $3,054 |
| 2020 | 55 | 18 | 0% (0) | 25% | $6,569 |
| 2019 | 37 | 21 | 0% (0) | None | $3,763 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Fluorouracil | 15 | $4,924 | $328 |
| Clobetasol Propionate | 32 | $2,843 | $89 |
| Tacrolimus | 11 | $2,771 | $252 |
| Triamcinolone Acetonide | 88 | $1,174 | $13 |
| Ketoconazole | 39 | $598 | $15 |
| Mupirocin | 31 | $398 | $13 |
| Hydrocortisone | 23 | $237 | $10 |
| Prednisone | 22 | $177 | $8 |
| Cephalexin | 11 | $146 | $13 |
2022: 5 drugs
| Ketoconazole | 35 | $1,229 | $35 |
| Clobetasol Propionate | 20 | $806 | $40 |
| Triamcinolone Acetonide | 50 | $705 | $14 |
| Hydrocortisone | 18 | $159 | $9 |
| Mupirocin | 16 | $92 | $6 |
Money from drug and device companies
$2,365 in 2025
| 2025 | 17 | 97 | None | $2,365 |
| 2024 | 20 | 173 | None | $4,092 |
| 2023 | 20 | 132 | None | $3,211 |
| 2022 | 11 | 36 | None | $854 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $387 | 18 payments
|
| Galderma Laboratories L.P. | Nemluvio | $329 | 8 payments
|
| Lilly USA | Taltz | $264 | 16 payments
|
| Regeneron Healthcare Solutions | Dupixent | $245 | 10 payments
|
| Genzyme | Dupixent | $219 | 7 payments
|
| Incyte | Opzelura | $194 | 8 payments
|
See all 97 published payments
| Incyte | Meals · 2025-12-18 | Opzelura | $24 |
| Organon | Meals · 2025-12-10 | None | $32 |
| Genzyme | Meals · 2025-11-25 | Dupixent | $22 |
| Galderma Laboratories L.P. | Meals · 2025-11-20 | Nemluvio | $18 |
| Sun Pharmaceutical Industries | Meals · 2025-11-12 | Winlevi | $17 |
| Incyte | Meals · 2025-11-06 | Opzelura | $19 |
| Organon | Meals · 2025-11-03 | None | $6 |
| Regeneron Healthcare Solutions | Meals · 2025-10-29 | Dupixent | $19 |
| Botanix SB | Meals · 2025-10-27 | Sofdra | $27 |
| Abbvie | Meals · 2025-10-23 | Skyrizi | $21 |
| Galderma Laboratories L.P. | Meals · 2025-10-22 | Nemluvio | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-10-16 | Libtayo | $28 |
| Incyte | Meals · 2025-10-15 | Opzelura | $16 |
| Janssen Biotech | Meals · 2025-10-01 | Tremfya | $33 |
| Janssen Biotech | Meals · 2025-09-26 | Tremfya | $26 |
| Incyte | Meals · 2025-09-25 | Opzelura | $33 |
| Organon | Meals · 2025-09-16 | None | $7 |
| Lilly USA | Meals · 2025-09-11 | Taltz | $15 |
| Organon | Meals · 2025-09-03 | None | $25 |
| Amgen | Meals · 2025-09-02 | Otezla | $26 |
| Janssen Biotech | Meals · 2025-08-13 | Tremfya | $25 |
| Botanix SB | Meals · 2025-08-07 | Sofdra | $26 |
| Lilly USA | Meals · 2025-07-25 | Taltz | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-07-16 | Dupixent | $29 |
| Botanix SB | Meals · 2025-07-03 | Sofdra | $30 |
| Genzyme | Meals · 2025-06-16 | Dupixent | $21 |
| Lilly USA | Meals · 2025-06-12 | Taltz | $32 |
| Lilly USA | Meals · 2025-06-11 | Taltz | $7 |
| Lilly USA | Meals · 2025-06-11 | Taltz | $7 |
| Genzyme | Meals · 2025-06-11 | Dupixent | $34 |
| Almirall | Meals · 2025-06-07 | Klisyri | $16 |
| Incyte | Meals · 2025-06-05 | Opzelura | $15 |
| LEO Pharma | Meals · 2025-06-05 | Adbry | $30 |
| Lilly USA | Meals · 2025-06-04 | Taltz | $25 |
| Abbvie | Meals · 2025-06-04 | Rinvoq | $15 |
| Abbvie | Meals · 2025-06-03 | Rinvoq | $30 |
| Galderma Laboratories L.P. | Meals · 2025-05-31 | Nemluvio | $14 |
| Genzyme | Meals · 2025-05-30 | Dupixent | $31 |
| Lilly USA | Meals · 2025-05-28 | Ebglyss | $7 |
| Lilly USA | Meals · 2025-05-28 | Ebglyss | $6 |
| Galderma Laboratories L.P. | Meals · 2025-05-24 | Nemluvio | $31 |
| Novartis Pharmaceuticals | Meals · 2025-05-19 | Cosentyx | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-05-17 | Dupixent | $27 |
| Botanix SB | Meals · 2025-05-09 | Sofdra | $21 |
| Abbvie | Meals · 2025-05-06 | Skyrizi | $12 |
| Lilly USA | Meals · 2025-05-05 | Taltz | $17 |
| Lilly USA | Meals · 2025-05-05 | Taltz | $14 |
| Regeneron Healthcare Solutions | Meals · 2025-05-03 | Dupixent | $23 |
| Galderma Laboratories L.P. | Meals · 2025-05-03 | Nemluvio | $36 |
| Revance Therapeutics | Meals · 2025-04-29 | Daxi | $33 |
| Abbvie | Meals · 2025-04-26 | Rinvoq | $28 |
| Sun Pharmaceutical Industries | Meals · 2025-04-24 | Winlevi | $29 |
| Lilly USA | Meals · 2025-04-21 | Taltz | $31 |
| Lilly USA | Meals · 2025-04-21 | Taltz | $3 |
| Abbvie | Meals · 2025-04-12 | Rinvoq | $31 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-10 | Sotyktu | $27 |
| Incyte | Meals · 2025-04-09 | Opzelura | $28 |
| Abbvie | Meals · 2025-04-04 | Rinvoq | $29 |
| Lilly USA | Meals · 2025-04-03 | Taltz | $27 |
| Genzyme | Meals · 2025-03-28 | Dupixent | $39 |
| Lilly USA | Meals · 2025-03-27 | Taltz | $31 |
| Regeneron Healthcare Solutions | Meals · 2025-03-22 | Dupixent | $27 |
| Abbvie | Meals · 2025-03-21 | Skyrizi | $10 |
| Abbvie | Meals · 2025-03-15 | Rinvoq | $32 |
| Abbvie | Meals · 2025-03-14 | Skyrizi | $8 |
| Incyte | Meals · 2025-03-14 | Opzelura | $29 |
| Genzyme | Meals · 2025-03-14 | Dupixent | $38 |
| Abbvie | Education · 2025-03-13 | Skyrizi | $10 |
| Regeneron Healthcare Solutions | Meals · 2025-03-12 | Dupixent | $18 |
| Regeneron Healthcare Solutions | Meals · 2025-03-08 | Dupixent | $28 |
| Organon | Meals · 2025-03-08 | Vtama | $23 |
| Galderma Laboratories L.P. | Meals · 2025-03-07 | Nemluvio | $35 |
| Novartis Pharmaceuticals | Meals · 2025-03-06 | Cosentyx | $21 |
| Genzyme | Meals · 2025-02-28 | Dupixent | $34 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $23 |
| Revance Therapeutics | Meals · 2025-02-27 | None | $28 |
| Novartis Pharmaceuticals | Meals · 2025-02-26 | Cosentyx | $19 |
| Abbvie | Meals · 2025-02-20 | Skyrizi | $10 |
| Insulet | Meals · 2025-02-18 | Omnipod | $42 |
| Lilly USA | Meals · 2025-02-12 | Taltz | $25 |
| Lilly USA | Meals · 2025-02-12 | Taltz | $3 |
| Regeneron Healthcare Solutions | Meals · 2025-02-08 | Dupixent | $21 |
| Janssen Biotech | Meals · 2025-01-31 | Tremfya | $29 |
| Organon | Meals · 2025-01-31 | Vtama | $8 |
| Organon | Meals · 2025-01-31 | Vtama | $16 |
| Regeneron Healthcare Solutions | Meals · 2025-01-30 | Dupixent | $26 |
| Revance Therapeutics | Meals · 2025-01-30 | Daxxify | $37 |
| Abbvie | Meals · 2025-01-28 | Skyrizi | $30 |
| Novartis Pharmaceuticals | Meals · 2025-01-27 | Cosentyx | $29 |
| Galderma Laboratories L.P. | Meals · 2025-01-25 | Nemluvio | $28 |
| Abbvie | Meals · 2025-01-24 | Skyrizi | $17 |
| Incyte | Meals · 2025-01-24 | Opzelura | $29 |
| Abbvie | Meals · 2025-01-23 | Rinvoq | $28 |
| Abbvie | Meals · 2025-01-17 | Skyrizi | $18 |
| Abbvie | Meals · 2025-01-17 | Rinvoq | $35 |
| Almirall | Meals · 2025-01-11 | Klisyri | $25 |
| Galderma Laboratories L.P. | Meals · 2025-01-09 | Nemluvio | $150 |
See earlier years (2024, 2023, 2022)
2024: $4,092
| Abbvie | Rinvoq | $981 | 44 payments
|
| Regeneron Healthcare Solutions | Dupixent | $658 | 22 payments
|
| Janssen Biotech | Tremfya | $324 | 10 payments
|
| Genzyme | Dupixent | $239 | 12 payments
|
| Lilly USA | Taltz | $223 | 9 payments
|
| Sun Pharmaceutical Industries | Winlevi | $216 | 8 payments
|
| Novartis Pharmaceuticals | Cosentyx | $212 | 11 payments
|
| Almirall | Klisyri | $191 | 6 payments
|
| Incyte | Opzelura | $153 | 9 payments
|
| Pfizer | Eucrisa | $145 | 9 payments
|
| Dermavant Sciences | Vtama | $132 | 10 payments
|
| Revance Therapeutics | Daxxify | $102 | 4 payments
|
| Amgen | Otezla | $95 | 3 payments
|
| Galderma Laboratories L.P. | None | $95 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $86 | 3 payments
|
| LEO Pharma | Adbry | $75 | 3 payments
|
| Arcutis Biotherapeutics | Zoryve | $74 | 4 payments
|
| Organogenesis | None | $43 | 1 payment
|
| Biofrontera | Ameluz | $26 | 1 payment
|
| Merz North America | None | $22 | 1 payment
|
2023: $3,211
| Genzyme | Dupixent | $637 | 18 payments
|
| AbbVie | Skyrizi | $601 | 24 payments
|
| Regeneron Healthcare Solutions | Dupixent | $413 | 17 payments
|
| Sun Pharmaceutical Industries | Winlevi | $201 | 5 payments
|
| Dermavant Sciences | Vtama | $194 | 8 payments
|
| Novartis Pharmaceuticals | Cosentyx | $171 | 10 payments
|
| LEO Pharma | Adbry | $169 | 8 payments
|
| Incyte | Opzelura | $129 | 10 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $92 | 4 payments
|
| Ucb | Cimzia | $91 | 4 payments
|
| Janssen Biotech | Remicade | $85 | 4 payments
|
| Arcutis Biotherapeutics | None | $83 | 4 payments
|
| Fresenius Kabi USA | Idacio | $77 | 3 payments
|
| Almirall | Klisyri | $61 | 2 payments
|
| Lilly USA | Taltz | $58 | 3 payments
|
| Pfizer | Eucrisa | $55 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $46 | 2 payments
|
| Biofrontera | Ameluz | $19 | 1 payment
|
| Galderma Laboratories L.P. | Epsolay | $16 | 1 payment
|
| Journey Medical | None | $14 | 1 payment
|
2022: $854
| Genzyme | Dupixent | $154 | 5 payments
|
| Janssen Biotech | Remicade | $139 | 6 payments
|
| Abbvie | Humira | $136 | 8 payments
|
| Regeneron Healthcare Solutions | Dupixent | $98 | 4 payments
|
| LEO Pharma | Adbry | $96 | 4 payments
|
| Ucb | Cimzia | $69 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $58 | 2 payments
|
| Merz North America | Xeomin | $36 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $27 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $25 | 1 payment
|
| Almirall | Klisyri | $15 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 98.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1932590205
- Licence
- CA A176366California A176366: Current · expires 2028-04-30
- Trained
- University of California, Davis School of Medicine, 2013
- Group
- Golden State Dermatology Associates, Inc. · Springhouse Dermatology Inc
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Student in a training program (390200000X)
- Mailing address
- 2490 Hospital Dr Ste 201, Mountain View, CA, 94040
- NPI first listed
- 2015-02-09
- NPI last updated
- 2022-06-23
- NPI record certified
- 2022-06-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 710 Lawrence Expy, Santa Clara, CA, 95051